Allergen-specific immunotherapy of allergy and asthma: current and future trends.

about

Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides Innate responses to pollen allergens.

P2860

Q36901292-399392DB-C00C-4EFC-9548-C37C97DF3869 Q38302630-39406517-7A2D-4E43-A980-B850ADCE0B42

P2860

Allergen-specific immunotherapy of allergy and asthma: current and future trends.

Item

http://www.wikidata.org/entity/Q40006542

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Allergen-specific immunotherapy of allergy and asthma: current and future trends.

@en

type

Item

label

Allergen-specific immunotherapy of allergy and asthma: current and future trends.

@en

prefLabel

Allergen-specific immunotherapy of allergy and asthma: current and future trends.

@en

P1476

Allergen-specific immunotherapy of allergy and asthma: current and future trends.

@en

P2093

Annette Leimgruber

http://www.w3.org/2001/XMLSchema#string

Christophe Reymond

http://www.w3.org/2001/XMLSchema#string

François Spertini

http://www.w3.org/2001/XMLSchema#string

P2860

T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method.

Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation.

Long-term clinical efficacy of grass-pollen immunotherapy.

Safety of sublingual-swallow immunotherapy in children and adults.

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen.

New insights into the role of cytokines in asthma

P304

37-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17476348.3.1.37

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477281

http://www.w3.org/2001/XMLSchema#string

P921

asthma

Allergen-specific immunotherapy of allergy and asthma: current and future trends.

about

P2860

P2860

Allergen-specific immunotherapy of allergy and asthma: current and future trends.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921